ストックスクリーナーアプリを入手
1.49
0.67%
-0.01
アフターアワーズ：
1.51
0.02
+1.34%
Autolus Therapeutics Plc Adr (AUTL) 最新ニュース
Autolus Therapeutics (AUTL) could find a support soon, here's why you should buy the stock now - MSN
Autolus Therapeutics Receives Prix Galien UK Award - GlobeNewswire Inc.
Autolus Therapeutics (AUTL) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Autolus Therapeutics PLC Sponsored ADR (AUTL) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Apellis Pharmaceuticals (APLS) moves 135.4% higher: Will this strength last? - MSN
Autolus Therapeutics Q1 Earnings Call Highlights - Yahoo Finance
Autolus Therapeutics (NASDAQ: AUTL) to cut 13% of staff, save $15M - Stock Titan
Autolus Therapeutics Eyes CAR-T Edge With AUCATZYL Safety, Expands Centers, Sees Margin Turnaround - Yahoo Finance
Autolus Therapeutics (NASDAQ: AUTL) registers $150M shelf for shares, ADSs, debt - Stock Titan
Autolus Therapeutics Highlights obe-cel Momentum in ALL With New Real-World ROKA and Pediatric Data - Yahoo Finance
Apellis Pharmaceuticals (APLS) Surges 135.4%: Can This Momentum Be Sustained? - Bitget
Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last? - Yahoo Finance
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives $8.50 Consensus Target Price from Analysts - Defense World
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Autolus Therapeutics Q4 Earnings Call Highlights - Yahoo Finance
Mak Capital One LLC Buys 9,062,518 Shares of Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat
Autolus Therapeutics Touts $75M Year-1 Obe-cel Launch, Sees $120M-$135M Revenue in 2026 - Yahoo Finance
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
What is HC Wainwright’s Estimate for AUTL FY2025 Earnings? - Defense World
Q1 Earnings Forecast for AUTL Issued By HC Wainwright - MarketBeat
What is HC Wainwright's Estimate for AUTL FY2025 Earnings? - MarketBeat
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
New Strong Sell Stocks for January 30th - Yahoo Finance
Autolus Therapeutics (NASDAQ:AUTL) Cut to Strong Sell at Zacks Research - Defense World
New Strong Sell Stocks for January 22nd - Yahoo! Finance Canada
Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Truist Securities lowers Autolus Therapeutics stock price target on soft guidance - Investing.com
Free cash flow per share of Autolus Therapeutics Plc Sponsored ADR – FWB:6A3A - TradingView — Track All Markets
Autolus Therapeutics (NASDAQ:AUTL) Price Target Raised to $11.00 at Needham & Company LLC - Defense World
Autolus Therapeutics (NASDAQ:AUTL) Trading Up 13.5% Following Analyst Upgrade - Defense World
Autolus Therapeutics stock jumps after Needham raises price target By Investing.com - Investing.com South Africa
Autolus Therapeutics stock jumps after Needham raises price target - Investing.com
Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? - Finviz
Perpetual Ltd Has $784,000 Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
The i-80 Gold Corp (IAUX) had a good session last reading, didn’t it? - uspostnews.com
Autolus Therapeutics’ (AUTL) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
Ryan Richardson joins Autolus Therapeutics board of directors - Investing.com
Autolus Therapeutics plc (AUTL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Autolus Therapeutics Surges: What’s Next for the Stock? - StocksToTrade
ADC Therapeutics SA (NYSE:ADCT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Are These 4 Biotech Stocks Set to Beat Q3 Earnings Estimates? - Yahoo Finance
Needham Keeps Buy Rating on Autolus (AUTL) with a $10 Target - Finviz
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks with ‘Strong Buy’ Ratings - Barchart.com
Gil Blum Analyst Performance at Needham & Company LLC - MarketBeat
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts - Yahoo Finance
AUTL Stock Price and Chart — NASDAQ:AUTL - TradingView — Track All Markets
symbol__ Stock Quote Price and Forecast - CNN
Autolus Therapeutics LtdADR (AUTL) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
Wells Fargo Maintains Autolus Therapeutics plcADR (AUTL) Overweight Recommendation - Nasdaq
AUTL Forecast — Price Target — Prediction for 2027 - TradingView — Track All Markets
What is the current Price Target and Forecast for Autolus Therapeutics (AUTL) - Zacks Investment Research
1.27%
1.43%
大文字化:
|
ボリューム (24 時間):